Metronidazole Hydrochloride: Clinical Trials

3 trials of Metronidazole Hydrochloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Early Phase 11Unknown 1

Follow Metronidazole Hydrochloride: new trials by email Literature Review of Metronidazole Hydrochloride trials Research Report on Metronidazole Hydrochloride

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Polyethylene Glycol, Neomycin, Metronidazole Hydrochloride - Colorectal Neoplasms, Diverticulitis
Early Phase 1UnknownThomas Jefferson University2242016-09-012018-08-22
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
bismuth subcitrate, amoxicillin, clarithromycin - Lymphoma
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC961997-09-012012-07-02
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
Amoxicillin, Bismuth Subsalicylate, Clarithromycin - Lymphoma
Phase 2CompletedM.D. Anderson Cancer Center51995-08-102018-10-24

Conditions studied

Lymphoma (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Colorectal Neoplasms (1)  ·  Diverticulitis (1)  ·  Inflammatory Bowel Diseases (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Surgical Wound Infection (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  M.D. Anderson Cancer Center (1)  ·  Thomas Jefferson University (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Benjamin Phillips, MD (1)  ·  Gideon Steinbach, MD, PhD (1)  ·  John W. Sweetenham, MD (1)  ·  Patrice P. Carde, MD (1)

Results publications

PMID 36748942

NIH funding

P30CA016672 (1)